Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies

The serine/threonine protein kinases CDK2 and GSK-3β are key oncotargets in breast cancer cell lines, therefore, in the present study three series of oxindole-benzofuran hybrids were designed and synthesised as dual CDK2/GSK-3β inhibitors targeting breast cancer (5a–g, 7a–h, and 13a–b). The N(1)-uns...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldehna, Wagdy M., Al-Rashood, Sara T., Al-Warhi, Tarfah, Eskandrani, Razan O., Alharbi, Amal, El Kerdawy, Ahmed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751407/
https://www.ncbi.nlm.nih.gov/pubmed/33327806
http://dx.doi.org/10.1080/14756366.2020.1862101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751407/
https://www.ncbi.nlm.nih.gov/pubmed/33327806
http://dx.doi.org/10.1080/14756366.2020.1862101

Ejemplares similares